Expression
Large-scale, low-cost expression of proteins and functional macromolecules on our next-generation cell-free platform.
- High-yield, stable circular mRNA
- Customizable hybrid lysate
- Dual-pathway energy regeneration
- GSH + chaperone protection
- Exclusive template specificity
- Next-gen DNase & RNase killers
- 01      PDB ID    Protein Data Bank identifier
- 02     Quantity    Approximate amount required
- 03     Quote    We reply with your price
Advanced protein expression,
delivered worldwide.
GMExpression delivers frontier protein-expression solutions to research institutions worldwide. Our competitive edge is CFPS+ — a next-generation cell-free platform integrating circular mRNA, hybrid lysate engineering, dual-pathway energy regeneration, and advanced auxiliary macromolecules to enable efficient, stable, and scalable production of proteins and functional biomolecules.
CFPS+
Worldwide
High-yield
CFPS+
Next-generation
cell-free synthesis
Long-lasting, high-yield, scalable expression of proteins and functional macromolecules. Engineered for durable templates, sustained translation, exclusive template/molecule utilization, and conformational fidelity.
Circular mRNA resists exonucleases, so reactions run longer and yield more than with linear mRNA.
A multi-strain lysate, customisable per target — compatible with diverse promoters and enriched for the tRNAs hard-to-express proteins need.
Two combinable in-vitro pathways sustain ATP supply, extending reaction lifetime well beyond traditional CFPS.
Yeast mitochondria-driven ATP
Pre-purified yeast mitochondria generate ATP continuously via oxidative phosphorylation.
- High energy density
- Prolonged reactions
- High-yield expression
Recombinant glycolysis + TCA
A recombinant enzyme module converts low-cost precursors into ATP.
- Low cost
- Sustainable supply
- Scales to large batches
GSH replaces DTT for a gentler, longer-lasting reducing environment, paired with chaperones for accurate folding of complex proteins.
A multi-strain lysate, customisable per target — compatible with diverse promoters and enriched for the tRNAs hard-to-express proteins need.